Dr Clive Glover, director, strategy at Pall Corporation, discusses the steps the pharmaceutical industry has taken to speed up the development of a Covid-19 vaccine.
Vaccine research
The world has been under lockdown for several months now. Although some locations have loosened restrictions, a safe and effective vaccination will be a crucial element in many countries’ “exit strategy” for Covid-19. The reimplementation of lockdown in Northeast China amid new clusters of infection is a grim reminder of that reality.
While development of a large-scale vaccine would traditionally take years to scale-up to mass production, the unprecedented scope of the pandemic has accelerated the timeline to months, not years. Every day saved in this process corresponds directly to lives saved.